4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-064352
Chief Executive Officer sold 7,800 shares at an average $33.88 ($264,233)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-12-27 | Sale | −3,247 | $32.82 | $106,567 | 16,431 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-12-27 | Sale | −653 | $34.19 | $22,326 | 15,778 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-12-28 | Sale | −3,400 | $34.60 | $117,640 | 12,378 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-12-28 | Sale | −500 | $35.40 | $17,700 | 11,878 | I |
| Open-market sales · 7,800 sh · avg $33.88 · $264,233 | |||||||
Loading xslF345X03/doc4.xml…